Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.
about
Stenotrophomonas maltophilia: an emerging global opportunistic pathogenMultidrug resistant acinetobacter.Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolatesInfections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity.In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011).Antimicrobial Resistance in Pseudomonas sp. Causing Infections in Trauma Patients: A 6 Year Experience from a South Asian Country.In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii.Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic procedures.SecA: a potential antimicrobial target.One cannot rule them all: Are bacterial toxins-antitoxins druggable?Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality.Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric PatientsImpact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children.Susceptibility Pattern and Distribution of Oxacillinases and bla PER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in IranIn Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.Expression, crystallization and preliminary X-ray crystallographic analysis of alanine racemase from Acinetobacter baumannii OXA-23Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Treatment options for multidrug-resistant nonfermenters.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Pharmacokinetic and pharmacodynamic evaluation of tigecycline.Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches.Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.Molecular Study of Acinetobacter baumannii Isolates for Metallo-β-Lactamases and Extended-Spectrum-β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt.Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.
P2860
Q26995336-15AEE468-FC13-4E26-9512-43F12F4E9290Q33711902-D89FBAD6-4FF0-44C6-AB31-A6F739B012AEQ33853131-ADC9AED9-FEA9-46D9-973E-1D846F940AB7Q33876665-069CF26D-ACC6-43F1-8D31-145C6EE25D60Q33882361-843D3433-DB1E-4495-92A3-E7B7CA575F1DQ33890690-B640900E-1C00-4D2E-88CA-6634D84122A8Q33892585-A8FD00FD-CDA1-4376-BC60-D2ACDB786C97Q34227180-666DAF3B-BC22-44A7-B24D-F2510CD2C937Q34483679-2936607F-CAB0-4F79-9EFD-631D10B5BF18Q34650225-7E6F1C96-01CB-4E94-AADF-ED16A23B9212Q34699065-A42EE0EA-AE2D-44F5-A389-37F782988A5DQ35076951-F96EBEDB-B453-4579-9912-30301A1FA1DCQ35127299-DA629496-82FB-417C-AF63-EB9206732A0EQ35270507-6675D2BC-4E1F-440B-B0D2-75122020827EQ35777207-AE9727B1-58E8-4D2E-A024-4B16ECD2D0D5Q35804736-8C842948-4A2F-4262-A390-FBBDBBC80AAEQ36037500-946400C3-A514-460A-A93B-231D64B2A658Q36172460-362CBBFA-CE54-4760-8A76-FAB71F360EAEQ36211901-3684EFB6-3669-451D-B04F-A996735BEC5FQ36229076-72D09782-148D-42FC-8773-452BE596B868Q36298237-AE1AB8B4-B03E-4AF9-A73B-54CA5AA24681Q36435455-47C8D36A-68FA-4659-9884-C93A87B6B679Q36529723-0831B947-ED3F-4C62-ABC7-2B2DC7579554Q36887890-ACFB1BA4-667B-416A-A717-EBDAB9485BACQ36912403-CC59F94E-8062-4497-973D-DD39B59C457EQ36937446-4E22A049-2FE8-458A-98A5-4FB6C774F897Q37134609-CCD1B5AD-EB12-4279-84AB-DDD9B1F3195DQ37307919-8951F28C-7316-4F41-A94A-1BB2E1B01900Q37656243-BBC76FAB-0905-4AD9-B37C-D17410002D2BQ37700555-33411953-44B3-418F-8AE1-56E367DF1467Q37869910-BE966CA0-A3BC-4FBE-92A0-222C6A3722FAQ37940546-C17246C0-2678-4E3B-A8FD-4305332FD600Q37970757-3099EE43-337F-4EF0-A313-B62D2A5819AFQ37984504-CD547A53-83AE-4A3E-AC05-F51815BB8729Q38086340-6371936E-323E-4732-B073-A1DC3C2EC2C3Q38543852-7D706809-9C5B-451C-B7F3-07268DDFEF96Q39062989-B98DA837-452B-4A9E-BF1B-FEB9CC3809E0Q40177316-BBEA2C69-6E00-441B-981B-582314DD4D70Q40190095-F79D70BE-6F2E-42B5-A5C3-E47CE6E42A99Q40402946-FBB03122-565A-461D-A20D-E3A0FAFD5491
P2860
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@en
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@nl
type
label
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@en
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@nl
prefLabel
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@en
Pandrug resistance (PDR), exte ...... harmonization in terminology.
@nl
P356
P1476
Pandrug resistance (PDR), exte ...... l harmonization in terminology
@en
P304
1121-2; author reply 1122
P356
10.1086/528867
P407
P577
2008-04-01T00:00:00Z